Table 3.
Cross tab data analysis; determining the significance of categorised variables on likelihood to present at follow-up or in interval
| Descriptive statistic: | Detected at follow-up: | Detected in interval: | p. value: |
|---|---|---|---|
|
Gender;
|
|
|
.413 |
| Female |
8 (21.6%) |
29 (78.4%) |
|
| Male |
15 (26.3%)′ |
42 (73.7%) |
|
|
Deprivation score;
|
|
|
.341 |
| 1(most deprived) |
3 (60.0%) |
2 (40.0%) |
|
| 2 |
3 (33.3%) |
6 (66.7%) |
|
| 3 |
6 (27.3%) |
16 (72.7%) |
|
| 4 |
7 (25.9%) |
20 (74.15) |
|
| 5(least deprived) |
4 (12.9%) |
27 (87.1%) |
|
|
Rurality;
|
|
|
.571 |
| Urban |
14 (32.6%) |
29 (67.4%) |
|
| Rural |
9 (17.6%) |
42 (82.4%) |
|
|
Melanoma type;
|
|
|
.964 |
| Superficial spreading |
7 (25.9%) |
20 (74.1%) |
|
| Nodular malignant |
8 (26.7%) |
22 (73.3%) |
|
| Lentigo maligna |
1 (20.0%) |
4 (80.0%) |
|
| Acral lentiginous |
1 (20.0% |
4 (80.0%) |
|
| Other |
6 (22.2%) |
21 (77.8%) |
|
|
Breslow thickness;
|
|
|
.252 |
| 4 mm or less |
11 (20.0%) |
44 (80.0%) |
|
| >4 mm |
12 (30.8%) |
27 (69.2%) |
|
|
Age at Dx;
|
|
|
.142 |
| Up to 65 years |
12 (25.0%) |
36 (75%) |
|
| 65 years and above |
18 (39.1%) |
28 (60.9%) |
|
|
Time to recurrence;
|
|
|
.008 |
| 12 months or less |
14 (51.9%) |
13 (48.1%) |
|
| Beyond 12 months | 16 (23.9%) | 51 (76.2%) |